Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Depreciation & Amortization
Mereo Biopharma Group PLC
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Depreciation & Amortization
£730k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Depreciation & Amortization
$810k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Depreciation & Amortization
$6.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Depreciation & Amortization
$6.6m
|
CAGR 3-Years
72%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Depreciation & Amortization
£4.1m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Depreciation & Amortization
£45.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
See Also
What is Mereo Biopharma Group PLC's Depreciation & Amortization?
Depreciation & Amortization
730k
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Depreciation & Amortization amounts to 730k GBP.
What is Mereo Biopharma Group PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
-23%
Over the last year, the Depreciation & Amortization growth was 14%. The average annual Depreciation & Amortization growth rates for Mereo Biopharma Group PLC have been -23% over the past three years .